Related Experiment Videos
[Clinical evaluation of immuno-serological laboratory data]
12nd Department of Internal Medicine, Fukushima Medical College.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|December 1, 1996
Summary
This review highlights key autoantibodies for diagnosing connective tissue vascular diseases (CVDs). Specific autoantibodies like IgA-RF in Sjögren syndrome and anti-dsDNA in SLE are crucial for disease evaluation.
Area of Science:
- Immunology
- Rheumatology
- Clinical Chemistry
Background:
- Autoantibodies are critical biomarkers in diagnosing and managing autoimmune diseases.
- Immuno-serological tests provide valuable data for understanding disease mechanisms and patient stratification.
Observation:
- Rheumatoid factors (RF) show varied positivity across diseases, with IgA-RF higher in Sjögren syndrome.
- Anti-nuclear antibody (ANA) frequency is notable in healthy individuals, while CH50 levels better reflect Systemic Lupus Erythematosus (SLE) activity than ANA titers.
- Specific autoantibodies like anti-cardiolipin, anti-centromere, and anti-neutrophil cytoplasmic antibodies are associated with thrombosis, CREST syndrome, and vasculitis.
Findings:
- Higher frequencies and titers of IgA-RF were observed in Sjögren syndrome patients.
- Erythrocyte Sedimentation Rate (ESR) and C-reactive protein (CRP) correlate with Rheumatoid Arthritis (RA) disease activity, unlike RF titers.
- ANA positivity was found in 40% of healthy young women, indicating potential for false positives.
- CH50 levels demonstrated a stronger correlation with clinical activity in SLE patients compared to ANA titers.
- Associations were noted between specific autoantibodies and various connective tissue vascular diseases (CVDs), including thrombosis, CREST syndrome, primary biliary cirrhosis, vasculitis, and inflammatory bowel disease.
Implications:
- Laboratory data from immuno-serological tests are essential for accurate diagnosis, disease activity assessment, and prognosis estimation in CVDs.
- Understanding the diagnostic utility of specific autoantibodies aids in targeted patient management.
- Further research into the clinical significance of autoantibody profiles can refine diagnostic and therapeutic strategies for autoimmune conditions.